A detailed history of Ggm Financials LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ggm Financials LLC holds 750 shares of LLY stock, worth $766,275. This represents 0.29% of its overall portfolio holdings.

Number of Shares
750
Previous 748 0.27%
Holding current value
$766,275
Previous $583 Million 1.95%
% of portfolio
0.29%
Previous 0.34%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$625.65 - $812.69 $1,251 - $1,625
2 Added 0.27%
750 $572 Million
Q2 2025

Aug 01, 2025

BUY
$713.71 - $898.95 $533,855 - $672,414
748 New
748 $583 Million
Q1 2025

Apr 11, 2025

BUY
$725.72 - $929.72 $725 - $929
1 Added 0.13%
747 $617 Million
Q4 2024

Jan 28, 2025

BUY
$727.2 - $932.06 $727 - $932
1 Added 0.13%
746 $576 Million
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $20,075 - $24,960
26 Added 3.62%
745 $660 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $521,181 - $653,599
719 New
719 $651 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ggm Financials LLC Portfolio

Follow Ggm Financials LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ggm Financials LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ggm Financials LLC with notifications on news.